Last viewed:
SRDX
Prices are updated after-hours
SRDX
|
$26.85
5.75%
5.44%
53K
|
Health Technology
(0.0% 1d)
(-7.5% 1m)
(7.4% 1y)
(0.0% 2d)
(0.0% 3d)
(-4.3% 7d)
(111.92%
volume)
Earnings Calendar: 2024-02-01
Market Cap: $ 382,236,600
http://www.surmodics.com
Sec
Filling
|
Patents
| 370 employees
(US) SurModics, Inc. engages in the provision of medical device and in vitro diagnostic technologies to the healthcare industry. It operates through the Medical Device and In Vitro Diagnostics segments. The Medical Device segment designs, develops, and manufactures interventional medical devices, surface modification coating technologies, as well as drug-delivery coating technologies. The In Vitro Diagnostics segment consists of component products and technologies for diagnostic test kits and biomedical research applications. The company was founded in June 1979 and is headquartered in Eden Prairie, MN.
drug delivery
diagnostics
add to watch list
Paper trade
email alert is off
Press-releases
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
Published: 2024-04-19
(Crawled : 13:00)
- biospace.com/
SRDX
|
$26.85
5.75%
5.44%
53K
|
Health Technology
| -4.26%
| O: -1.06%
H: 3.24%
C: 0.95%
report
financial
results
In Vitro Diagnostics Market Worth $119.4 billion | MarketsandMarkets™
Published: 2024-03-27
(Crawled : 14:30)
- prnewswire.com
QGEN
|
$41.89
1.63%
0.0%
900K
|
Health Technology
| -3.47%
| O: 0.02%
H: 0.28%
C: 0.09%
DHR
|
$253.11
7.21%
0.0%
6.8M
|
Health Technology
| -4.98%
| O: 0.56%
H: 0.16%
C: -0.43%
BIO
|
$285.28
1.84%
0.0%
230K
|
Health Technology
| -17.73%
| O: 0.62%
H: 2.18%
C: 2.02%
BDX
|
$234.36
0.21%
0.0%
800K
|
Health Technology
| -3.31%
| O: 0.57%
H: 1.36%
C: 1.34%
A
|
$139.2
3.95%
-0.14%
2M
|
Health Technology
| -7.27%
| O: 0.86%
H: 1.26%
C: 1.18%
ABT
|
News
|
$107.59
0.49%
-0.09%
3.8M
|
Health Technology
| -3.05%
| O: 1.48%
H: 0.0%
C: 0.0%
SRDX
|
$26.85
5.75%
5.44%
53K
|
Health Technology
| -10.0%
| O: 0.99%
H: 2.11%
C: 1.09%
QGEN
|
$41.89
1.63%
0.0%
900K
|
Health Technology
| -3.47%
| O: 0.02%
H: 0.28%
C: 0.09%
ILMN
|
$124.41
3.46%
3.34%
1.3M
|
Health Technology
| -10.13%
| O: 1.28%
H: 2.34%
C: 2.34%
HOLX
|
$77.19
1.27%
1.26%
1.6M
|
Health Technology
| 0.07%
| O: 0.56%
H: 1.01%
C: 0.98%
AXDX
|
$0.949
6.94%
6.49%
140K
|
Health Technology
| -7.32%
| O: 4.13%
H: 1.0%
C: 1.0%
diagnostics
market
Surmodics to Participate in Upcoming Investor Conferences in March and April
Published: 2024-02-27
(Crawled : 13:30)
- biospace.com/
SRDX
|
$26.85
5.75%
5.44%
53K
|
Health Technology
| -23.01%
| O: 1.24%
H: 0.54%
C: -0.39%
Surmodics Reports First Quarter of Fiscal Year 2024 Financial Results; Updates Fiscal Year 2024 Financial Guidance
Published: 2024-02-01
(Crawled : 14:00)
- biospace.com/
SRDX
|
$26.85
5.75%
5.44%
53K
|
Health Technology
| -27.89%
| O: -3.72%
H: 9.88%
C: -4.34%
first
year
financial
Drug-Eluting Balloons Global Market is Expected to Expand at a Healthy Growth Rate of ~8% by 2028, Predicts DelveInsight
Published: 2024-01-24
(Crawled : 22:00)
- prnewswire.com
TRUMF
|
$16.488
-17.59%
1.7K
|
Health Technology
| -50.73%
| O: 3.54%
H: 0.0%
C: 0.0%
TRUMY
|
$16.94
0.79%
52K
|
Manufacturing
| -49.93%
| O: -0.3%
H: 0.18%
C: -0.06%
PHG
|
News
|
$21.01
1.94%
0.0%
2M
|
Health Technology
| -9.76%
| O: 0.0%
H: 0.57%
C: 0.48%
LLY
|
News
|
$745.69
1.96%
-0.16%
2M
|
Health Technology
| 15.41%
| O: -1.0%
H: 0.84%
C: 0.04%
BSX
|
$68.99
1.43%
0.19%
9.1M
|
Health Technology
| 12.78%
| O: 0.58%
H: 0.98%
C: 0.93%
SRDX
|
$26.85
5.75%
5.44%
53K
|
Health Technology
| -27.04%
| O: 1.03%
H: 0.0%
C: -1.34%
expected
global
growth
market
Surmodics Announces Successful Early Clinical Use of Pounce™ LP (Low Profile) Thrombectomy System, Designed to Address a Critical, Unmet Need by Facilitating Removal of Thrombi and Emboli Below the Knee
Published: 2024-01-22
(Crawled : 13:30)
- biospace.com/
SRDX
|
$26.85
5.75%
5.44%
53K
|
Health Technology
| -25.26%
| O: -0.18%
H: 1.92%
C: -0.8%
removal
Surmodics to Host Virtual Annual Meeting of Shareholders - January 16, 2024
Published: 2024-01-16
(Crawled : 14:00)
- biospace.com/
SRDX
|
$26.85
5.75%
5.44%
53K
|
Health Technology
| -24.73%
| O: -1.3%
H: 1.02%
C: 0.63%
meeting
Surmodics to Report First Quarter of Fiscal 2024 Financial Results on February 1
Published: 2024-01-16
(Crawled : 14:00)
- biospace.com/
SRDX
|
$26.85
5.75%
5.44%
53K
|
Health Technology
| -24.73%
| O: -1.3%
H: 1.02%
C: 0.63%
first
report
financial
results
Surmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposium
Published: 2023-11-16
(Crawled : 15:30)
- biospace.com/
SRDX
|
$26.85
5.75%
5.44%
53K
|
Health Technology
| -24.93%
| O: 0.0%
H: 1.21%
C: 0.62%
trial
Surmodics to Participate in the Piper Sandler Healthcare Conference on November 28
Published: 2023-11-14
(Crawled : 00:00)
- biospace.com/
SRDX
|
$26.85
5.75%
5.44%
53K
|
Health Technology
| -21.54%
| O: 4.02%
H: 2.91%
C: 2.91%
conference
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0000950170-24-012234
4
2024-02-07
2024-02-05
Sell
M
3932
0
0000950170-24-012234
4
2024-02-07
2024-02-05
Sell
F
3063
33204
0000950170-24-012234
4
2024-02-07
2024-02-05
Buy
M
3932
36267